Article November 16, 2021 Accure Therapeutics presented at ECTRIMS four communications reporting the progress of ACT-01 neuroprotective therapy for Multiple Sclerosis + Read more
Article May 21, 2020 New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis + Read more
